Welcome
to the Taj Pharmaceuticals Limited India site. We would like to give you
an overview of Taj Pharmaceuticals Limited in India: our background,
organization, products, core belief and prospects.
| We at Taj Pharmaceuticals Limited India are committed to our customers and employees and, more importantly, to the people who rely on our medicines. We plan to move forward with greater vigour and a clearer vision to put each and every individual at the heart of our commitment, working for healthier India – health. With the creation of Taj Pharmaceuticals Limited, we now have access to one of the richest and most innovative research pipelines in the pharmaceutical industry. We're building on our history of hard work, diligence and success, by working tirelessly to enhance the value we are committed to provide towards improving health and the quality of lives across the world. |
Taj Pharma is one of the
leading generic pharmaceutical company in India. We hold top
positions in different established markets worldwide and are
building a strong presence in many emerging generics markets.
Today, we market more than 500 branded and 4600 generics compositions to consumers in more than 40 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products.
At Taj Pharma, we are always ready to meet the challenges of the dynamic global pharmaceutical industry with its numerous and wide-ranging issues – from complex research, development and regulatory conditions to rapidly changing consumer demands.
Our Generics portfolio offers over 1500 products in the major therapeutic areas of gastro-intestinal, cardiovascular, pain management, oncology, anti-infectives, paediatrics and dermatology. Brands like Alzocum®, Benacof, Wallbrurate®, Coversec, Cadrol, Humogen and Merokem enjoy leadership positions in several key markets, including India, Russia & other countries.
Our deep customer relationships, quality medicines and consistently delivered promise make us a trusted brand across the world.
We have capitalized on every opportunity to bring our high-quality products to more people around the world. A synchronized supply chain that leverages our strong product development capabilities, state-of-the-art manufacturing and vertical integration with our own APIs has created a creditable track record of successful launches.
Our generics offerings deliver quality at cost-effective prices in the highly regulated markets of the United States, UK and other Asian countries.
Today, we market more than 500 branded and 4600 generics compositions to consumers in more than 40 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products.
At Taj Pharma, we are always ready to meet the challenges of the dynamic global pharmaceutical industry with its numerous and wide-ranging issues – from complex research, development and regulatory conditions to rapidly changing consumer demands.
Our Generics portfolio offers over 1500 products in the major therapeutic areas of gastro-intestinal, cardiovascular, pain management, oncology, anti-infectives, paediatrics and dermatology. Brands like Alzocum®, Benacof, Wallbrurate®, Coversec, Cadrol, Humogen and Merokem enjoy leadership positions in several key markets, including India, Russia & other countries.
Our deep customer relationships, quality medicines and consistently delivered promise make us a trusted brand across the world.
We have capitalized on every opportunity to bring our high-quality products to more people around the world. A synchronized supply chain that leverages our strong product development capabilities, state-of-the-art manufacturing and vertical integration with our own APIs has created a creditable track record of successful launches.
Our generics offerings deliver quality at cost-effective prices in the highly regulated markets of the United States, UK and other Asian countries.
AJ PHARMA MANUFACTURING
With our world class technology, we work with built systems that meet the most stringent international manufacturing standards. Expert quality teams ensure that systems and processes remain in compliance with the latest standards and international markets.
Our plants hold approvals from the FDA and compliment regulatory authorities.
Manufacturing Plants / Units
Virtual Tour of Plants
FormulationWe make specialty formulations across a range of dosage forms- oral, injectable and delivery system based.
API
We make specialty API’s including peptides, steroids, hormones and anticancer at internationally approved world-class sites.
Quality
PolicyRegularly updated systems, procedures and an expert team support a stringent quality policy.
Our facilities has been approved by WHO-GMP and several international regulators across the semi-regulated markets. It caters to the bulk of the demand for solid orals, liquid orals, and external creams and powders across markets in Asia, Africa, Middle East, Russia and Latin America.
The company is presently expanding this facility and building a dedicated export oriented unit to cater to growth in demand for its exclusive generics (4600), solid orals, semi-solid and liquid orals range of formulations in semi-regulated markets.
Test Equipment and Facilities : The manufacturing facilities are based in Mehsana, (Gujarat), Baroda, Sarigam (Daman and Diu) and Raigad (Puna Expressway, Maharashtra) and operated by Taj Pharmaceuticals Ltd.
In our quest to be
the leading manufacturer in the pharmaceutical
industry and a Generics
player of global standing; we
aspire to meet and excel the highest industry
standards. To this end, on the manufacturing front, we
have designed and engineered our production facilities
to the most rigorous benchmarks and according to the
guidelines of
world health organisation.
We operate with modern
facility for the production of
sterile powder formulations, non-sterile oral
formulations and active pharmaceutical ingredients.
Some other features of our facility:
* Modern QA, QC, Microbiological and PD Lab supported with high-tech equipment.
* Fully automated with electronically controlled operating system as per Good Automated Manufacturing Practice guidelines.
* Sophisticated Effluent Treatment Plant (ETP) with a capacity of 100,000 liters per day.
* Conforms to international environmental, health & safety regulations
Our facility consistently meets and exceeds our own stringent quality assurance standards, administered by an Internal Quality Assurance team reporting directly to the Managing Director, as well as those imposed by regulatory bodies. IQ /OQ / PQ validations have been completed on all equipment to which these apply.
In addition, we are a registered drug manufacturing facility with an impressive inspection record. All our manufacturing sites are WHO-GMP approved.
Our expertise APIs (CTD & formulation dossiers) will help us further enhance our own product range as well as the size and diversity of our toll / contract manufacturing business segment.
Modern methods like aqueous coating, tablet packing in combi-packs etc., are implemented in the manufacturing process.
player of global standing; we
aspire to meet and excel the highest industry
standards. To this end, on the manufacturing front, we
have designed and engineered our production facilities
to the most rigorous benchmarks and according to the
guidelines of
world health organisation.We operate with modern
facility for the production of
sterile powder formulations, non-sterile oral
formulations and active pharmaceutical ingredients.Some other features of our facility:
* Modern QA, QC, Microbiological and PD Lab supported with high-tech equipment.
* Fully automated with electronically controlled operating system as per Good Automated Manufacturing Practice guidelines.
* Sophisticated Effluent Treatment Plant (ETP) with a capacity of 100,000 liters per day.
* Conforms to international environmental, health & safety regulations
Our facility consistently meets and exceeds our own stringent quality assurance standards, administered by an Internal Quality Assurance team reporting directly to the Managing Director, as well as those imposed by regulatory bodies. IQ /OQ / PQ validations have been completed on all equipment to which these apply.
In addition, we are a registered drug manufacturing facility with an impressive inspection record. All our manufacturing sites are WHO-GMP approved.
Our expertise APIs (CTD & formulation dossiers) will help us further enhance our own product range as well as the size and diversity of our toll / contract manufacturing business segment.
Modern methods like aqueous coating, tablet packing in combi-packs etc., are implemented in the manufacturing process.
The Hyderabad plant is the ONLY plant in the world producing
all the effective ranges of Anti-tuberculosis formulations
namely Ethambutol Hydrochloride (B.P.), Rifampicin
(B.P.), Isoniazid (B.P.), Pyrazinamide (B.P.), Rifampicin-Isoniazid
(B.P.), Rifampicin-Isoniazid-Pyrazinamide (B.P.),
Ethionamide (B.P.) and Prothionamide (B.P.) - all
in Tablet form. Production of bulk actives such as
Ethambutol, Rifampicin and Pyrazinamide are also undertaken
at Valsad, Gujrat (India).
R & D activity is a continuous on-going process
and the R & D Division at all Units and has been duly
approved by the Department of Scientific and Industrial
Research, (DSIR), Government of India.
The API Plant, which is involved in Fermentation activity has been suitably up-graded and manufactures products like - Lovastatin, Simvastatin, DMCTC, Gentamycin, Sisomycin, etc., The Plant also exclusively manufactures a veterinary product range for a foreign multinational, - in addition Taj Pharma India is one of the few suppliers of this product in the market.
on www.tajpharma.com
VisionThe API Plant, which is involved in Fermentation activity has been suitably up-graded and manufactures products like - Lovastatin, Simvastatin, DMCTC, Gentamycin, Sisomycin, etc., The Plant also exclusively manufactures a veterinary product range for a foreign multinational, - in addition Taj Pharma India is one of the few suppliers of this product in the market.
on www.tajpharma.com
"Our vision is to be a leading pharmaceutical company in India and to become a significant global player by providing high quality, affordable and innovative solutions in medicine and treatment. "
Mission
"We will discover, develop and successfully market pharmaceutical products to prevent, diagnose, alleviate and cure diseases”.
We shall provide total customer satisfaction and achieve leadership in chosen markets, products and services across the globe, through excellence in technology, based on world-class research and development.
Know more about Manufacturing :
Welcome to Taj Pharma
Medicines Product Manufacturer....
Taj Pharma in Mumbai is the economical capital city of India, has a powerful element of social responsibility inscribed in its' values and its' concern for the society beyond its' business motives. Alleviation of the sufferings of mankind, availability of the medicines to all at affordable price without any discrimination and continued efforts to improve the quality of the medicines are our values and mission.
Taj Pharma is an ideal choice for forming sustainable relationships in the fields of :
• International business.
• Marketing tie-up.
• Contract manufacturing in to international standards.
• Distribution tie-ups with a range of over 500 products (and growing).
In short we are,
• Driven by a vision to alleviate suffering.
• Pharma not with just a Healing Touch but a vision.
• Committed to complete customer care.
We are committed to
• Make health affordable to all.
• Allow access to the best.
• Employ well researched Modern Technology.
• Seamless delivery of Products & Services of International Standards.
• Strive for disease free and healthy millennium.
We are offering
• Latest products and many more...
• Dedicated Units for the Production of various medicines.
• Expertise in a Wide Range of Pharma Services.
• Exporting of products to all over world.
We have Recognition from
• Drug Control Department, India
• Directorate General of Health Services, India
We are into
• Concentrated research in Generics, Drug discovery & Development
Quality Control - Manufacturing Setup
Taj Pharma in Mumbai is the economical capital city of India, has a powerful element of social responsibility inscribed in its' values and its' concern for the society beyond its' business motives. Alleviation of the sufferings of mankind, availability of the medicines to all at affordable price without any discrimination and continued efforts to improve the quality of the medicines are our values and mission.
Taj Pharma is an ideal choice for forming sustainable relationships in the fields of :
• International business.
• Marketing tie-up.
• Contract manufacturing in to international standards.
• Distribution tie-ups with a range of over 500 products (and growing).
In short we are,
• Driven by a vision to alleviate suffering.
• Pharma not with just a Healing Touch but a vision.
• Committed to complete customer care.
We are committed to
• Make health affordable to all.
• Allow access to the best.
• Employ well researched Modern Technology.
• Seamless delivery of Products & Services of International Standards.
• Strive for disease free and healthy millennium.
We are offering
• Latest products and many more...
• Dedicated Units for the Production of various medicines.
• Expertise in a Wide Range of Pharma Services.
• Exporting of products to all over world.
We have Recognition from
• Drug Control Department, India
• Directorate General of Health Services, India
We are into
• Concentrated research in Generics, Drug discovery & Development
Quality Control - Manufacturing Setup
Manufacturing :Manufacturing and Facilities : The manufacturing facilities are based in Valsad (Gujarat) and Raigad (Raigarh, Maharashtra) and operated by Taj Pharmaceuticals Ltd and its subsidiaries.
In our quest to be the leading
manufacturer in the pharmaceutical industry and a exporter of
global standing; we aspire to meet and excel the highest industry
standards. To this end, on the manufacturing front, we have
designed and engineered our production facilities to the most
rigorous benchmarks.
 We manufacture under modern 
facilities for the production of sterile powder formulations,
non-sterile oral formulations and active pharmaceutical
ingredients. Some other features of our facility: * Modern QA, QC, Microbiological and PD Lab supported with high-tech equipment. * Fully automated with electronically controlled operating system as per Good Automated Manufacturing Practice guidelines (GMP). * Sophisticated Effluent Treatment Plant (ETP) with a capacity of 100,000 liters per day. * Conforms to international environmental, health & safety regulations Our facility consistently meets and exceeds our own stringent quality assurance standards, administered by an Internal Quality Assurance team reporting directly to the Managing Director, as well as those imposed by regulatory bodies. IQ /OQ / PQ validations have been completed on all equipment to which these apply. In addition, we are a registered drug manufacturing facility with an impressive inspection record. All our manufacturing sites are WHO-GMP approved. Our expertise APIs (CTD & formulation dossiers) will help us further enhance our own product range as well as the size and diversity of our toll / contract manufacturing business segment. Modern methods like aqueous coating, tablet packing in combi-packs etc., are implemented in the manufacturing process.
The API supplies plant is the ONLY
plant in the world producing all the effective ranges of
Anti-tuberculosis formulations namely Ethambutol Hydrochloride (B.P.),
Rifampicin (B.P.), Isoniazid (B.P.), Pyrazinamide (B.P.),
Rifampicin-Isoniazid (B.P.), Rifampicin-Isoniazid-Pyrazinamide (B.P.),
Ethionamide (B.P.) and Prothionamide (B.P.) - all in Tablet form.
Production of bulk actives such as Ethambutol, Rifampicin and
Pyrazinamide are also undertaken at Valsad, Gujrat (India).
R & D
activity is a continuous on-going process and the R & D
Division at All facilities has been duly approved by the Department of
Scientific and Industrial Research, (DSIR), Government of India.
The Hyderabad Plant, which is involved in Fermentation activity has been suitably up-graded and manufactures products like - Lovastatin, Simvastatin, DMCTC, Gentamycin, Sisomycin, etc., The Plant also exclusively manufactures a veterinary product for a foreign multinational - in fact is the only manufacturer of this product in the world. |
